| 1. | | Recruiting | Stroke Prevention in Sickle Cell Anemia (STOP 2)
Conditions: Blood Disease; Cerebrovascular Accident; Anemia, Sickle Cell |
| 2. | | Recruiting | Study of Transfusion-Transmitted Infections
Condition: Virus Disease |
| 3. | | Recruiting | Transfer of GPI-Linked Proteins to Transfused Patients with Paroxysmal Nocturnal Hemoglobinuria
Condition: Paroxysmal Hemoglobinuria |
| 4. | | Not yet recruiting | Silent Cerebral Infarct Multi-Center Clinical Trial
Conditions: Sickle Cell Anemia; Stroke |
| 5. | | Recruiting | Genetic Studies of Chronic Active Epstein-Barr Disease
Condition: Epstein-Barr Virus Infections |
| 6. | | Recruiting | Selective T-Cell Depletion to Reduce Graft-Versus-Host-Disease in Patients Receiving Stem Cell Transplantation to Treat Leukemia, Lymphoma or Myelodysplastic Syndromes
Conditions: Graft vs Host Disease; Myelodysplastic Syndromes; Leukemia; Leukemia, Myeloid; Leukemia, Myelomonocytic, chronic; Leukemia, Lymphocytyc; Lymphoma; ... |
| 7. | | Recruiting | Mobilization of Stem Cells with G-CSF for Collection from Patients with Diamond-Blackfan Anemia
Condition: Diamond Blackfan Anemia |
| 8. | | Recruiting | Modified Stem Cell Transplantation Procedure for Treating Chronic Granulomatous Disease
Condition: Chronic Granulomatous Disease |
| 9. | | Recruiting | Late Effects of Treatment for Sarcomas in Children
Condition: Sarcoma |
| 10. | | Recruiting | Stem Cell Transplant with Th2/Tc2 Cells to Treat Advanced Breast Cancer
Condition: Breast Neoplasms |
| 11. | | Recruiting | Modified Stem Cell Transplant Procedure to Treat Patients with Blood and Immune System Cancers
Condition: Hematologic Neoplasms |
| 12. | | Recruiting | Sirolimus to Prevent GVHD after Stem Cell Transplant for Blood Cancers
Conditions: Hematologic Neoplasms; Neural Tube Defects; Myeloproliferative Disorders |
| 13. | | Recruiting | Stem Cell Transplantation in Patients with High-Risk and Recurrent Pediatric Sarcomas
Condition: Sarcoma |
| 14. | | Recruiting | Tariquidar and Docetaxel to Treat Patients with Lung, Ovarian, and Cervical Cancer
Conditions: Lung Neoplasms; Ovarian Neoplasms; Cervix Neoplasms |
| 15. | | Recruiting | Phase I Trial of MEDI-507 in CD2-Positive Lymphoproliferative Disease
Condition: Lymphoproliferative Disorders |
| 16. | | Recruiting | Doxercalciferol in Treating Patients With Myelodysplastic Syndrome or Chronic Myelomonocytic Leukemia
Conditions: Chronic Myelomonocytic Leukemia; previously treated myelodysplastic syndromes; secondary myelodysplastic syndromes; de novo myelodysplastic syndromes; ... |
| 17. | | Recruiting | Thalidomide and Epoetin alfa in Treating Anemia in Patients With Myelodysplastic Syndrome
Conditions: de novo myelodysplastic syndromes; secondary myelodysplastic syndromes; previously treated myelodysplastic syndromes; Anemia; ... |
| 18. | | Recruiting | Research Into the Treatment of Anemia for Critically Ill Patients Admitted to Intensive Care Units (ICU)
Condition: Anemia |
| 19. | | Not yet recruiting | Transfusion Medicine/Hemostasis Clinical Research Network
Conditions: Purpura, Thrombocytopenic; Blood Disease |
| 20. | | Recruiting | Functional Outcomes in Cardiovascular Patients Undergoing Surgical Hip Fracture Repair (FOCUS)
Conditions: Anemia; Blood Disease; Blood Transfusion; Cardiovascular Diseases; Heart Diseases; Myocardial Infarction; Thromboembolism; Pneumonia; ... |
| 21. | | Recruiting | Inhaled Nitric Oxide and Transfusion Therapy for Patients with Sickle Cell Anemia and Secondary Pulmonary Hypertension
Conditions: Sickle Cell Anemia; Pulmonary Hypertension |
| 22. | | Recruiting | Treatment of Hemochromatosis
Condition: Hemochromatosis |
| 23. | | Recruiting | Stem Cell Transplantation and T-Cell Add-Back to Treat Bone Marrow Malignances
Conditions: Leukemia; Bone Marrow Transplantation |
| 24. | | Recruiting | CC-5013 in Treating Patients With Transfusion-Dependent Low-Risk or Intermediate-Risk Myelodysplastic Syndrome
Conditions: Chronic Myelomonocytic Leukemia; previously treated myelodysplastic syndromes; de novo myelodysplastic syndromes; ... |
| 25. | | Recruiting | Compassionate Use of Stanate (TM) Stannsoporfin
Conditions: Neonatal Jaundice; Jaundice; Hyperbilirubinemia |
| 26. | | Recruiting | Gene Message (mRNA) Analysis of Granulocytes
Condition: Neutropenia |
| 27. | | Recruiting | Stem Cell Transplantation to Treat Systemic Mastocytosis
Condition: Mastocytosis |
| 28. | | Recruiting | Stem Cell Mobilization Potential in Patients with Aplastic Anemia in remission
Condition: Aplastic Anemia |
| 29. | | Recruiting | Specimen Procurement from People with Hereditary Pulmonary Fibrosis
Condition: Pulmonary Fibrosis |
| 30. | | Recruiting | Prevalence and Risk of Cataracts in Granulocyte Donors
Condition: Apheresis |
| 31. | | Recruiting | BL22 Immunotoxin to Treat Hairy Cell Leukemia
Condition: Leukemia, Hairy Cell |
| 32. | | Recruiting | Lower-Dose Chemotherapy and Stem Cell Transplantation to Treat Childhood Leukemias and Lymphomas
Conditions: Hodgkin Lymphoma; Lymphocytic Leukemia; Mixed Cell Leukemia; Myelodysplastic Syndrome; Non Hodgkin's Lymphoma |
| 33. | | Recruiting | Study of Darbepoetin Alfa for the Treatment of Anemia of Cancer
Conditions: Anemia; Cancer |
